Aldeyra Therapeutics earnings were -$55.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ALDX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$15.8M, up 4.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ALDX reported annual earnings of -$55.9M, with 48.8% growth. The next ALDX earnings date is Apr 30, 2025.
Aldeyra Therapeutics Earnings Reports & History FAQ
What were Aldeyra Therapeutics's earnings last quarter?
On ALDX's earnings call on Invalid Date, Aldeyra Therapeutics (NASDAQ: ALDX) reported Q4 2024 earnings per share (EPS) of -$0.27, up 237.5% year over year. Total ALDX earnings for the quarter were -$15.81 million. In the same quarter last year, Aldeyra Therapeutics's earnings per share (EPS) was -$0.08.
The next ALDX earnings call is Invalid Date. Add ALDX to your watchlist to be reminded of Aldeyra Therapeutics's next earnings date.
What was ALDX's earnings growth in the past year?
As of Aldeyra Therapeutics's earnings date in Invalid Date, Aldeyra Therapeutics's earnings has grown year over year. ALDX earnings in the past year totalled -$55.85 million.
Is Aldeyra Therapeutics profitable or losing money?
As of the last Aldeyra Therapeutics earnings report, Aldeyra Therapeutics is currently losing money. Aldeyra Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$55.85 million, a 48.77% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.